| Outcome Measures: |
Primary: Urinary aldosterone at 3 months, Overnight urinary aldosterone compared to pretreatment level., 3 months | Secondary: Change in gastrointestinal microbiota., Fecal microbiota will be compared to pre-treatment sample., At 1 month after starting treatment, at 3 months and 12 months.|Urinary aldosterone at 12 months, Overnight urinary aldosterone at 12 months compared to pretreatment level., 12 months | Other: Serum adrenocorticotropic hormone, Change in adrenocorticotropic hormone in serum compared to pretreatment level., At 3 months and 12 months.|Plasma cortisol, Change in plasma cortisol compared to pretreatment level, At 3 months and 12 months.|Urinary cortisol, Change in overnight urinary cortisol compared to pretreatment level., At 3 months and 12 months.|Plasma aldosterone, Change in plasma aldosterone compared to pretreatment level., At 3 months and 12 months.|Plasma renin, Change in plasma renin compared to pretreatment level., At 3 months and 12 months.|Serum sodium, Change in serum sodium compared to pretreatment level., At 3 months and 12 months.|Serum potassium, Change in serum potassium compared to pretreatment level., At 3 months and 12 months.|Glycated hemoglobin A1c, Change in glycated hemoglobin A1c compared to pretreatment level., At 3 months and 12 months.|Ceruloplasmin, Change in plasma ceruloplasmin compared to pretreatment level., At 3 months and 12 months.|Ferritin, Change in plasma ferritin compared to pretreatment level., At 3 months and 12 months.
|
